We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,700.00
Bid: 1,700.00
Ask: 1,700.50
Change: -5.00 (-0.29%)
Spread: 0.50 (0.029%)
Open: 1,705.00
High: 1,711.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Women struggling to crack glass ceiling in top UK companies-report

Wed, 26th Mar 2014 15:17

* Women now hold fifth of FTSE 100 board positions

* Few women on executive committees with only 4 CEOs

* Campaigners push for voluntary change, not quotas (Adds new quotes, numbers, after report launch)

By Belinda Goldsmith

LONDON, March 26 (Reuters) - More women are sitting on theboards of Britain's blue-chip companies but the glass ceilingis yet to crack, with most top jobs still held by men andcompanies needing to do more to promote women, a governmentreport said on Wednesday.

The third annual progress report found women now occupy afifth, or 20.7 percent, of positions in FTSE 100 companies, upfrom 12.5 percent in 2011, within striking distance of a targetfor women to account for one quarter of board seats by 2015.

But campaigners admitted there was still a long way to go aswomen only account for 6.9 percent of senior executive roles inthe FTSE 100 where there are only four women chief executives.

Two companies in the FTSE 100, commodities trader GlencoreXstrata and miner Antofagasta, still haveall-male boards - although they told Reuters they are seekingfemale directors - and 48 FTSE 250 companies have all-maleboards.

Former trade minister Mervyn Davies, leader of thegovernment initiative since 2011, said the figures showed avoluntary drive to boost women around the boardroom table wasworking and ruled out the need for mandatory quotas such asthose introduced in France, Italy, Spain and the Netherlands andplanned for Germany.

He said the key to lasting improvement was encouragingcompanies to drive change within, not legislation or governmentintervention that critics argue can lead to tokenism and "trophydirectors".

"This is about changing the culture of corporate Britain,and using a stick is not the best way to do that," Davies toldReuters after launching the latest report in London.

"Everyone now sees that (having more women on boards) isgreat business sense so the debate is now moving from theboardroom to executive committees."

BUSINESS CREDIBILITY

He said Britain was leading the way at driving corporatechange on a voluntary basis rather than with quotas which arenow being mulled in the European Union.

But he said companies whether public or private had to stepup to the mark and he has written to all companies in the FTSE350 urging them to find ways to boost female representation.

"Failure would again raise the unwelcome proposal ofcompulsory measures. British business credibility is at stakeand we need to redouble our efforts," Davies said.

Minister for Women Maria Miller said companies needed to behonest that the culture in Britain was not neutral and it wasstill "white, male and heterosexual".

The only FTSE 100 female CEOs are Moya Greene at Royal Mail, Carolyn McCall at easyJet, Angela Ahrendts atBurberry and Alison Cooper at Imperial Tobacco.

Capita and Diageo had the highest proportionof women among FTSE 100 boards at 44 percent, followed by RoyalMail, Unilever, and GlaxoSmithKline.

Miller said corporate change was needed to address genderimbalance as well as the pay gap between men and women and ruleson executive pay.

"Women don't need special treatment. They just need an equalplaying field," she said.

With the spotlight on promoting women, several British banksreleased targets on gender balance in their annual results forthe first time this year.

HSBC aims to have women in 25 percent of seniorroles by 2014/15, up from 22.7 percent; Lloyds has atarget of 40 percent by 2020 compared to 28 percent now; andBarclays is eyeing 26 percent by 2018, up 5 points.

Davies, the former chief executive of Standard Chartered, said it was "inconceivable in this day and age" tohave an all-male board or executive committee.

"A company that does not get the mood of society on thisissue actually deserves to go out of business," he said. (Additional reporting by Steve Slater, Editing by AlisonWilliams)

More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.